Document is current
Any future updates will be listed below
-
Authors
Salari, Zohreh
Khosravi, Ahmad
Riahi, Arezo
Molaakbari, Elaheh
Salarkia, Ehsan
Keyhani, Ali Reza
Sohbati, Samira
Mansouri, Ghazal
Khosravi, Mina
Zarif, Mohammad
Estabragh, Mohammad Amin Raeisi
-
Funding
Funding for this research was provided by:
Kerman University of Medical Sciences (403000093)
- License Information
-
More Information
Article History
Received: 26 August 2025
Accepted: 19 November 2025
First Online: 26 November 2025
Declarations
:
: This study was approved by the Research Ethics Committees of Afzalipour Hospital, Kerman University of Medical Sciences (Approval ID: IR.KMU.AH.REC.1403.149).
: Not applicable.
: The authors declare no competing interests.
: Abbreviations .
: - Cisplatin (CIS).
: - Combination Index (CI).
: - Dulbecco’s Modified Eagle Medium (DMEM).
: - Encapsulation Efficiency (EE).
: - Enzyme-linked immuno_sorbent assay (ELISA).
: - Fetal Bovine Serum (FBS).
: - Flow Rate (TFR).
: - Flow Rate Ratio (FRR).
: - Inhibitory Concentrations (IC50).
: - Mefloquine (MEF).
: - Niosomal Mefloquine (NMEF).
: - Nuclear Factor kappa B (NF-κB).
: - Optical Density (OD).
: - Phosphate-Buffered Saline (PBS).
: - Polydispersity Index (PDI).
: - quantitative Real-Time PCR (qPCR).
: - Reactive Oxygen Species (ROS).
: - Selective Index (SI).
: - Triple-Negative Breast Cancer (TNBC).
: - Vascular Endothelial Growth Factor (VEGF).
: - Vascular Endothelial Growth Factor Receptor (KDR).
